BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8720902)

  • 1. Depletion of cellular iron by bps and ascorbate: effect on toxicity of adriamycin.
    Nyayapati S; Afshan G; Lornitzo F; Byrnes RW; Petering DH
    Free Radic Biol Med; 1996; 20(3):319-29. PubMed ID: 8720902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of redox-active iron bound to high molecular weight structures in nuclei with inhibition of cell growth by H2O2.
    Li H; Byrnes RW
    Free Radic Biol Med; 1999 Jan; 26(1-2):49-60. PubMed ID: 9890640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ascorbic acid in transferrin-independent reduction and uptake of iron by U-937 cells.
    May JM; Qu ZC; Mendiratta S
    Biochem Pharmacol; 1999 Jun; 57(11):1275-82. PubMed ID: 10230771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for involvement of multiple iron species in DNA single-strand scission by H2O2 in HL-60 cells.
    Byrnes RW
    Free Radic Biol Med; 1996; 20(3):399-406. PubMed ID: 8720911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridoxal isonicotinoyl hydrazone inhibits iron-induced ascorbate oxidation and ascorbyl radical formation.
    MaurĂ­cio AQ; Lopes GK; Gomes CS; Oliveira RG; Alonso A; Hermes-Lima M
    Biochim Biophys Acta; 2003 Mar; 1620(1-3):15-24. PubMed ID: 12595068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells.
    Brandt KE; Falls KC; Schoenfeld JD; Rodman SN; Gu Z; Zhan F; Cullen JJ; Wagner BA; Buettner GR; Allen BG; Berg DJ; Spitz DR; Fath MA
    Redox Biol; 2018 Apr; 14():82-87. PubMed ID: 28886484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves fenton-derived free radical generation.
    Chaston TB; Watts RN; Yuan J; Richardson DR
    Clin Cancer Res; 2004 Nov; 10(21):7365-74. PubMed ID: 15534113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimodal pattern of killing of Chinese hamster V79 variant cells by hydrogen peroxide.
    Kaneko M; Kodama M; Inoue F
    Free Radic Res; 1994 Apr; 20(4):229-39. PubMed ID: 8205225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism.
    Lane DJ; Chikhani S; Richardson V; Richardson DR
    Biochim Biophys Acta; 2013 Jun; 1833(6):1527-41. PubMed ID: 23481043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate.
    Hermes-Lima M; Ponka P; Schulman HM
    Biochim Biophys Acta; 2000 Oct; 1523(2-3):154-60. PubMed ID: 11042379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents.
    Doroshow JH
    Biochem Biophys Res Commun; 1986 Feb; 135(1):330-5. PubMed ID: 3954778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of superoxide and myeloperoxidase in ascorbate oxidation in stimulated neutrophils and H2O2-treated HL60 cells.
    Parker A; Cuddihy SL; Son TG; Vissers MC; Winterbourn CC
    Free Radic Biol Med; 2011 Oct; 51(7):1399-405. PubMed ID: 21791243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of bleomycin in iron- and copper-deficient cells.
    Lyman S; Taylor P; Lornitzo F; Wier A; Stone D; Antholine WE; Petering DH
    Biochem Pharmacol; 1989 Dec; 38(23):4273-82. PubMed ID: 2480795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.
    Richardson DR; Ponka P
    J Lab Clin Med; 1994 Nov; 124(5):660-71. PubMed ID: 7964124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of ascorbate-dependent, iron-catalyzed lipid peroxidation.
    Miller DM; Aust SD
    Arch Biochem Biophys; 1989 May; 271(1):113-9. PubMed ID: 2712569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
    Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
    Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione peroxidase protects cultured mammalian cells from the toxicity of adriamycin and paraquat.
    Taylor SD; Davenport LD; Speranza MJ; Mullenbach GT; Lynch RE
    Arch Biochem Biophys; 1993 Sep; 305(2):600-5. PubMed ID: 8373199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron requirement for cellular DNA damage and growth inhibition by hydrogen peroxide and bleomycin.
    Radtke K; Lornitzo FA; Byrnes RW; Antholine WE; Petering DH
    Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):655-64. PubMed ID: 7524474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of iron transfer from rabbit transferrin to reticulocytes using synthetic chelating agents.
    Morgan EH
    Biochim Biophys Acta; 1971 Jul; 244(1):103-16. PubMed ID: 5000975
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.